Speaker illustration

Doctor Soohyung Park

Korea University Guro Hospital, Seoul (Korea (Republic of))

Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

Event: ESC Congress 2025

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Pharmacotherapy in acute coronary syndromes (5)

Thumbnail

Impact of beta-blocker nebivolol versus carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with reduced LVEF treated with drug-eluting stents

Event: ESC Congress 2025

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Pharmacotherapy in acute coronary syndromes (4)

Thumbnail

Impact of Beta-Blocker Prescription at Discharge on Long-term Clinical Outcomes in ST elevation Myocardial Infarction Patients with Reduced LVEF treated with Drug-eluting Stents

Event: ESC Congress 2025

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Pharmacotherapy in acute coronary syndromes (1)

Thumbnail

The association between the dietary salt intake and glucose intolerance in the non-diabetic populations: from the Korean National Health and Nutritional Examination Survey (KNHANES)

Event: ESC Congress 2024

Topic: Public Health

Session: Cardiovascular health: from autoantibodies to healthcare utilisation

Thumbnail

Ten-year major clinical outcomes between first- and second-generation drug-eluting stents in hypertensive patients underwent percutaneous coronary intervention

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension in special circumstances

Thumbnail

Ten-year major clinical outcomes between first- and second-generation Drug-Eluting Stents in unstable angina patients underwent Percutaneous Coronary Intervention

Event: ESC Congress 2023

Topic: Unstable Angina

Session: Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes

Thumbnail

Adjunctive cilostazol in patients with acute ST-elevation myocardial infarction: a multicenter, randomized, open-label, phase 4 trial

Event: ESC Congress 2023

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: RCT in acute coronary syndromes: new developments

Thumbnail

ESC 365 is supported by